0001213900-23-097689.txt : 20231221
0001213900-23-097689.hdr.sgml : 20231221
20231221161338
ACCESSION NUMBER: 0001213900-23-097689
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisblum Eric
CENTRAL INDEX KEY: 0001569077
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41512
FILM NUMBER: 231505441
MAIL ADDRESS:
STREET 1: 285 GRAND AVENUE
CITY: ENGLEWOOD
STATE: NJ
ZIP: 07631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silo Pharma, Inc.
CENTRAL INDEX KEY: 0001514183
STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 462137136
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 677 N. WASHINGTON BLVD
CITY: SARASOTA
STATE: FL
ZIP: 34236
BUSINESS PHONE: (718) 400-9031
MAIL ADDRESS:
STREET 1: 677 N. WASHINGTON BLVD
CITY: SARASOTA
STATE: FL
ZIP: 34236
FORMER COMPANY:
FORMER CONFORMED NAME: Uppercut Brands, Inc.
DATE OF NAME CHANGE: 20190808
FORMER COMPANY:
FORMER CONFORMED NAME: Point Capital, Inc.
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: Gold Swap Inc
DATE OF NAME CHANGE: 20110301
4
1
ownership.xml
X0508
4
2023-12-19
0
0001514183
Silo Pharma, Inc.
SILO
0001569077
Weisblum Eric
C/O SILO PHARMA, INC.
560 SYLVAN AVE., SUITE 3160
ENGLEWOOD CLIFFS
NJ
07632
1
1
0
0
CEO and President
0
Common Stock
2023-12-19
4
P
0
500
1.63
A
169724
D
Common Stock
2023-12-20
4
P
0
200
1.61
A
169924
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.65. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.63. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Eric Weisblum
2023-12-21